EUDA Health receives listing noncompliance notice from Nasdaq

EUDA Health (EUDA) received a written notice from the Listing Qualifications Department of Nasdaq on April 23 indicating that the company had failed to maintain a Minimum Market Value of Listed Securities of $35M over the last 32 consecutive business days. The MVLS Notice has no immediate effect on the listing of the company’s securities on Nasdaq and the company has been provided a period of 180 calendar days from the date of the MVLS Notice, or until October 20, 2026, in which to regain compliance. In order to regain compliance, the Market Value of Listed Securities of the company must close at $35M or more for a minimum of ten consecutive business days during the MVLS Compliance Period. In the event that the company does not regain compliance with Nasdaq Listing Rules within the period, Nasdaq will provide notice to the company that its listed securities will be subject to delisting. The company may appeal Nasdaq’s determination to delist its securities.